(Q35116154)

6 August 2017

1 reference

title

Adhesion molecules as therapeutic targets for autoimmune diseases and transplant rejection (English)

1 reference

6 August 2017

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

28 December 2023

author name string

Sarah Bodary

2

1 reference

6 August 2017

Russell L. Dedrick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12718733

28 December 2023

Marvin R. Garovoy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12718733

28 December 2023

language of work or name

English

0 references

publication date

1 February 2003

1 reference

full work available at URL

6 August 2017

http://www.tandfonline.com/doi/pdf/10.1517/14712598.3.1.85

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

Expert Opinion on Biological Therapy

28 December 2023

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

85-95

1 reference

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Lymphocyte homing and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Chemokines, chemokine receptors, and allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Anti-P-selectin monoclonal antibody attenuates reperfusion injury to the rabbit ear.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

The effect of adhesion molecule blockade on pulmonary reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Improvements in early behavior of rat kidney allografts after treatment of the brain-dead donor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Adhesion receptors of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

The immunological synapse: a molecular machine controlling T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Three-dimensional segregation of supramolecular activation clusters in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Anti-adhesion antibodies efalizumab, a humanized anti-CD11a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Treatment of murine lupus with monoclonal antibodies to lymphocyte function-associated antigen-1: dose-dependent inhibition of autoantibody production and blockade of the immune response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Immune-adhesion molecules in the prevention of allograft rejection and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

The pathogenesis of psoriasis: immunological facts and speculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Homing of in vitro-generated donor antigen-reactive CD4+ T lymphocytes to renal allografts is alpha 4 beta 1 but not alpha L beta 2 integrin dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

alpha4 integrin in islet allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Endothelial-leukocyte adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.85

Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow

21 January 2018

9

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

Expression of adhesion molecules in allograft renal dysfunction. A distinct diagnostic pattern in rejection and cyclosporine nephrotoxicity

28 December 2023

10

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

Increased expression of adhesion receptors in both lesional and non-lesional psoriatic skin

28 December 2023

13

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

The adhesion molecule and cytokine profile of multiple sclerosis lesions

28 December 2023

14

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

E-selectin, but not P-selectin, is required for development of adjuvant-induced arthritis in the rat

28 December 2023

16

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins

28 December 2023

20

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

Activation of inflammatory mediators in rat renal isografts by donor brain death

28 December 2023

23

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1

28 December 2023

40

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies

28 December 2023

43

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

Population pharmacokinetics and pharmacodynamics of the anti-CD11a antibody hu1124 in human subjects with psoriasis.

28 December 2023

48

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody

28 December 2023

51

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

Stimulation through intercellular adhesion molecule-1 provides a second signal for T cell activation

28 December 2023

53

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients

28 December 2023

56

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1

28 December 2023

57

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

T lymphocyte migration to arthritic joints and dermal inflammation in the rat: differing migration patterns and the involvement of VLA-4

28 December 2023

67

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7

28 December 2023

72

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

VCAM-1 influences lymphocyte proliferation and cytokine production during mixed lymphocyte responses

28 December 2023

77

154

LUKAS NW

1994

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking

28 December 2023

78

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

VCAM-1, but Not ICAM-1 or MAdCAM-1, Immunoblockade Ameliorates DSS-Induced Colitis in Mice

28 December 2023

79

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.85

28 December 2023

Identifiers

1 reference

6 August 2017

1 reference